in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Novo Nordisk invests over $100 million in new purification plant in Denmark
7:28 AM MDT | March 17, 2014 | Deepti Ramesh
Health-care company Novo Nordisk (Bagsvaerd, Denmark) says it is increasing its drug development capacity by investing 550 million Danish kroner ($102 million) in a new facility at Bagsvaerd. The purification plant will expand the company’s capacity to produce active pharmaceutical ingredients for a growing number of diabetes drugs under development, Novo Nordisk says. The pilot plant will be fully operational by late 2016 and will be run by CMC Supply—chemistry, manufacturing, and control supply—a unit within Novo Nordisk R&D. CMC Supply...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee